60 related articles for article (PubMed ID: 3698049)
1. Phase II study of mitoguazone in pancreatic cancer: a Southwest Oncology Group Study.
Inamasu MS; Oishi N; Chen TT; Kraut EH; Grozea PN; Costanzi JJ; Bonnet JD
Cancer Treat Rep; 1986 Apr; 70(4):531-2. PubMed ID: 3698049
[No Abstract] [Full Text] [Related]
2. Phase II evaluation of mitoguazone in cancers of the esophagus, stomach, and pancreas: a Southeastern Cancer Study Group Trial.
Ravry MJ; Omura GA; Hill GJ; Bartolucci AA; Velez-Garcia E
Cancer Treat Rep; 1986 Apr; 70(4):533-4. PubMed ID: 3698050
[No Abstract] [Full Text] [Related]
3. Mitoguazone in advanced renal carcinoma: a phase II trial of the Southwest Oncology Group.
Knight WA; Drelichman A; Fabian C; Bukowski RM
Cancer Treat Rep; 1983 Dec; 67(12):1139-40. PubMed ID: 6652631
[No Abstract] [Full Text] [Related]
4. Methyl-GAG in advanced colon cancer: a phase II trial of the Southwest Oncology Group.
Knight WA; Loesch DM; Leichman LP; Fabian C; O'Bryan RM
Cancer Treat Rep; 1982 Dec; 66(12):2099-100. PubMed ID: 7139653
[No Abstract] [Full Text] [Related]
5. Phase I-II trial of methyl-GAG in advanced colon cancer. a Southwest Oncology Group pilot study.
Myers JW; Knight WA; Livingston RB; Fabian C; Costanzi J
Cancer Clin Trials; 1981; 4(3):277-9. PubMed ID: 7285275
[TBL] [Abstract][Full Text] [Related]
6. Mitoguazone in advanced squamous cell carcinoma of head and neck origin: a phase II trial of the Southeastern Cancer Study Group.
Luedke DW; Maddox W; Birch R; Velez-Garcia E; Schleuter J
Cancer Treat Rep; 1986 Apr; 70(4):529-30. PubMed ID: 3698048
[No Abstract] [Full Text] [Related]
7. Phase II evaluation of mitoguazone in metastatic hormone-resistant prostate cancer: a Southeastern Cancer Study Group trial.
Moore MR; Graham SD; Birch R; Irwin L
Cancer Treat Rep; 1987 Jan; 71(1):89-90. PubMed ID: 3791273
[No Abstract] [Full Text] [Related]
8. Phase II trial of mitoguazone in patients with advanced head and neck cancer.
Thongprasert S; Bosl GJ; Geller NL; Wittes RE
Cancer Treat Rep; 1984 Oct; 68(10):1301-2. PubMed ID: 6525604
[No Abstract] [Full Text] [Related]
9. Phase II trial of mitoguazone in children with leukemia and lymphoma: a Pediatric Oncology Group Study.
Kinney TR; Krischer JP; Starling KA; Alvarado C; Kamen B
Cancer Treat Rep; 1986 Aug; 70(8):1041-2. PubMed ID: 3524835
[No Abstract] [Full Text] [Related]
10. Phase II trial of amsacrine in pancreatic carcinoma: a Southwest Oncology Group study.
Inamasu M; Oishi N; Chen T; Legha S; McCracken J; Balcerzak S; Stephens R; O'Bryan R; Rivkin SE; Costanzi JJ
Cancer Treat Rep; 1984 Nov; 68(11):1411-2. PubMed ID: 6548661
[No Abstract] [Full Text] [Related]
11. Phase II trial of mitoguazone in patients with relapsed small cell carcinoma of the lung.
Scher H; Chapman R; Kelsen D; Gralla R; Wittes R
Cancer Treat Rep; 1984 Mar; 68(3):561-2. PubMed ID: 6322989
[No Abstract] [Full Text] [Related]
12. Phase II evaluation of diaziquone in pancreatic carcinoma: a Southwest Oncology Group Study.
Tilchen EJ; Fleming T; Mills G; Oishi N; Bonnett JD; Natale RB; Harker G; Coltman CA
Cancer Treat Rep; 1987 Dec; 71(12):1309-10. PubMed ID: 3690548
[No Abstract] [Full Text] [Related]
13. Phase II trial of methyl-GAG in advanced renal cancer.
Zeffren J; Yagoda A; Watson RC; Natale RB; Blumenreich MS; Chapman R; Howard J
Cancer Treat Rep; 1981; 65(5-6):525-7. PubMed ID: 6263478
[No Abstract] [Full Text] [Related]
14. Phase II trial of mitoguazone in patients with advanced squamous cell carcinoma of the head and neck.
Perry DJ; Crain SM; Weltz MD; Wilson JP; Davis RK; Woolley PV; Forastiere AA; Taylor HG; Weiss RB
Cancer Treat Rep; 1983 Jan; 67(1):91-2. PubMed ID: 6616496
[TBL] [Abstract][Full Text] [Related]
15. Phase II study of methyl-GAG in the treatment of esophageal carcinoma.
Kelsen D; Chapman R; Bains M; Heelan R; Dukeman M; Golbey R
Cancer Treat Rep; 1982 Jun; 66(6):1427-9. PubMed ID: 7083245
[TBL] [Abstract][Full Text] [Related]
16. Phase II trial of mitogauzone in malignant primary brain tumors.
Feun LG; Yung WK; Stewart DJ; Savaraj N; Bodey GP
Cancer Treat Rep; 1985 Mar; 69(3):329-30. PubMed ID: 3978660
[TBL] [Abstract][Full Text] [Related]
17. [Phase II trial of mitoguazone in patients with recurrent extensive cervicofacial tumors].
Coninx P; Nasca S; Jezekova D; Roelandt H; Morel M; Legros M; Cattan A
Bull Cancer; 1985; 72(2):153-4. PubMed ID: 4005436
[No Abstract] [Full Text] [Related]
18. Response of nude mouse-grown adenocarcinomas of the human exocrine pancreas to cis-diamminedichloroplatinum(II), diammine[1,1-cyclobutanedicarboxylato(2-)-O,O'-platinum], and mitoguazone dihydrochloride.
Kyriazis AP; Kyriazis AA; Yagoda A; Fogh J
Cancer Res; 1985 Sep; 45(9):4354-9. PubMed ID: 3896479
[TBL] [Abstract][Full Text] [Related]
19. Phase II evaluation of MGBG in non-small cell carcinoma of the lung. A Southwest Oncology Group study.
Vance RB; Knight WA; Chen TT; Costanzi JJ; LoBuglio AF
Invest New Drugs; 1983; 1(1):89-93. PubMed ID: 6678859
[TBL] [Abstract][Full Text] [Related]
20. Phase II evaluation of methyl-GAG in patients with refractory metastatic breast cancer.
Yap HY; Blumenschein GR; Schell F; Bodey GP
Cancer Treat Rep; 1981; 65(5-6):465-7. PubMed ID: 7237467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]